NCT00004810View on ClinicalTrials.gov

Phase II Placebo-Controlled Study of 4-Aminosalicylic Acid for Ulcerative Colitis

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 1996

Conditions
Ulcerative Colitis
Interventions
DRUG

-aminosalicylic acid

All Listed Sponsors
collaborator

University of Vermont

OTHER

lead

National Center for Research Resources (NCRR)

NIH

NCT00004810 - Phase II Placebo-Controlled Study of 4-Aminosalicylic Acid for Ulcerative Colitis | Biotech Hunter | Biotech Hunter